Leap Therapeutics, Inc(NASDAQ:LPTX) 
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, ...
Website: http://www.leaptx.com
Founded: 2011
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.30
H 0.31
L 0.22
C 0.27
V 904,149
10EMA 0.27
20EMA 0.27
60EMA 0.27
120EMA 0.27
250EMA 0.27